The firm said at the JP Morgan Healthcare Conference that a pivotal Phase III study, testing daraxonrasib in RAS-mutant ...

NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...

In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...

Research suggests vitamin D supplements may help some people with prediabetes restore normal blood sugar levels when combined with healthy lifestyle changes.

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

Ellie joined UNILAD in 2024, specialising in SEO and trending content. She moved from Reach PLC where she worked as a senior journalist at the UK’s largest regional news title, the Manchester Evening ...

Former Sen. Ben Sasse, R-Neb., announced Tuesday that he has been diagnosed with "metastasized, stage-four pancreatic cancer," writing in an X post that the diagnosis is "a death sentence." "Last week ...

Former GOP Sen. Ben Sasse revealed Tuesday that he has been diagnosed with Stage 4 pancreatic cancer and does not have long to live. In a lengthy statement on X, the 53-year-old said bluntly: “Last ...

Former Sen. Ben Sasse (R-Neb.) announced Tuesday he has been diagnosed with Stage 4 pancreatic cancer. The former two-term senator, 53, wrote in a lengthy social media post that he received the ...